• Profile
How and when to consider PCSK9 inhibitors in practice
Date: Sat 18 May, 2019 2:00–3:00pm
Duration: 1 hour

The session will cover

  1. The optimal LDL-C goal for patients with hypercholesterolemia at increased risk for cardiovascular events
  2. Appropriate selection of patients for non-statin lipid-lowering therapy
About the presenter:
Vector smart object 1565693496
Dr. JJ Dalal, Director of Centre for Cardiac Sciences at KDAH Mumbai

Dr. JJ Dalal is a revered name in the field of Cardiology. With a unique blend of a triple doctorate, his understanding of cardiology and his expertise in the areas of  interventional cardiology, cardio-thoracic surgery and cardiovascular surgery is undisputed. 
Dr. JJ Dalal has pioneered the angiography program in Mumbai in 1984. He has performed more than 20000 procedures for coronary angiography in his career spanning more than 35 years.  He has numerous publications in International and National journals. He is a faculty on International Conferences and Workshops.
Currently, Dr. JJ Dalal is the Director of Centre for Cardiac Sciences at Kokilaben Hospital. He has performed thousands of Cardiac Cath procedures at Kokilaben Hospital since its inception. 



  • Fellow of the European Society of Cardiology
  • Fellow and a member in Royal College of Physicians, London
  • Awarded as Young Researcher Award (British Cardiac Society, 1981)
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen